Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Coya Therapeutics (COYA) Return on Equity (2022 - 2025)

Coya Therapeutics' Return on Equity history spans 4 years, with the latest figure at 0.72% for Q3 2025.

  • For Q3 2025, Return on Equity fell 40.0% year-over-year to 0.72%; the TTM value through Sep 2025 reached 0.72%, down 40.0%, while the annual FY2024 figure was 0.4%, 19.0% up from the prior year.
  • Return on Equity for Q3 2025 was 0.72% at Coya Therapeutics, down from 0.71% in the prior quarter.
  • Across five years, Return on Equity topped out at 1.43% in Q4 2022 and bottomed at 2.84% in Q1 2023.
  • The 4-year median for Return on Equity is 0.49% (2024), against an average of 0.57%.
  • The largest annual shift saw Return on Equity crashed -177bps in 2023 before it surged 254bps in 2024.
  • A 4-year view of Return on Equity shows it stood at 1.43% in 2022, then tumbled by -124bps to 0.35% in 2023, then plummeted by -33bps to 0.46% in 2024, then crashed by -56bps to 0.72% in 2025.
  • Per Business Quant, the three most recent readings for COYA's Return on Equity are 0.72% (Q3 2025), 0.71% (Q2 2025), and 0.51% (Q1 2025).